Zimmer Biomet Holdings (LTS:0QQD) Total Stockholders Equity : CHF10,793 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Zimmer Biomet Holdings Total Stockholders Equity?

Zimmer Biomet Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was CHF10,793 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Zimmer Biomet Holdings's Book Value per Share for the quarter that ended in Dec. 2023 was CHF52.50. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Zimmer Biomet Holdings's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.47.

Zimmer Biomet Holdings Total Stockholders Equity Historical Data

The historical data trend for Zimmer Biomet Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zimmer Biomet Holdings Total Stockholders Equity Chart

Zimmer Biomet Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

12,172.55

10,833.33

11,660.51

11,198.11

10,793.14

Zimmer Biomet Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															11,198.11	11,245.47	11,139.30	11,254.72	10,793.14

Zimmer Biomet Holdings (LTS:0QQD) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Zimmer Biomet Holdings's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(10793.136	-	0)	/	205.6
	=	52.50

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Zimmer Biomet Holdings's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(778.32	+	4334.896)	/	10793.136
	=	0.47

Zimmer Biomet Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Zimmer Biomet Holdings (LTS:0QQD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (LTS:0QQD) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ZBH:USA ZIM:Germany ZBH:Austria

Address

345 East Main Street, Warsaw, IN, USA, 46580

Website

https://www.zimmerbiomet.com

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Zimmer Biomet Holdings (LTS:0QQD) Headlines

No Headlines